Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Glow Lifetech Corp C.GLOW

Alternate Symbol(s):  GLWLF

Healthcare Cannabis
Glow LifeTech Corp. is a Canada-based biotechnology company focused on producing nutraceutical and cannabinoid-based products. It is engaged in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100... see more

Recent & Breaking News (CSE:GLOW)

Glow LifeTech (CSE:GLOW) begins clinical study on patients with long COVID

John Ballem  December 29, 2021

Glow LifeTech Announces Commencement of Clinical Study of Artemic Support Featuring MyCell Technology on Patients with Long COVID

Newsfile December 24, 2021

Glow Completes Buildout of Canadian Facility and Begins Commissioning Proprietary Reactor

Newsfile November 9, 2021

Glow LifeTech Reports Positive Preclinical Data on Proprietary MyCell CBD Demonstrating Superior Bioavailability and Rapid Onset Time

Newsfile November 4, 2021

Glow Engages Regulatory Consultant Firms to Advance Commercialization of Artemic(TM) and Other Nutraceutical Ingredients in U.S. and Mexico

Newsfile October 27, 2021

Glow Takes Receipt of MyCell Reactor for Prototyping and Formulation for Canadian Processing; Receives CSA Standards Approval

Newsfile October 25, 2021

Glow LifeTech Strengthens Management Team with Manufacturing and Product Development Leaders; Provides Management Overview

Newsfile October 14, 2021

Glow LifeTech Announces Upgrade to OTCQB Under Ticker 'GLWLF'

Newsfile August 16, 2021

Glow Acquires Strategic Equity Investment in Nova Mentis

Newsfile August 10, 2021

Glow LifeTech (CSE:GLOW) begins build-out to bring MyCell® cannabis products to the Canadian market

Brieanna McCutcheon  May 28, 2021

Glow LifeTech Secures Canadian Processing Facility, Begins Build-out to Produce Next-Generation Cannabis Ingredients

Newsfile May 28, 2021

Glow LifeTech (CSE:GLOW) releases ArtemiC research with positive implications for COVID-19 variants

Trevor Abes  May 11, 2021

Glow LifeTech Reports on Additional Research Results on ArtemiC and Positive Implications for COVID-19 Variants

Newsfile May 11, 2021

Glow LifeTech Announces Successful First Commercial Production of ArtemiC(TM) for Global Distributor and a Second Production Scaled to Meet Growing Global Demand

Newsfile May 4, 2021

Glow LifeTech (CSE:GLOW) files natural health product ArtemiC™ with Health Canada

John Ballem  April 28, 2021

Glow LifeTech Submits Application to Health Canada for Natural Health Product Following Successful COVID-19 Phase II Clinical Trial

Newsfile April 27, 2021

Relay Medical Congratulates Glow LifeTech Corp. For Its Listing on the CSE Under Ticker "GLOW"

Newsfile March 15, 2021